Intelligence Profile
Safety Profile
Evidence Limitation Disclaimer: The available evidence on magnesium threonate safety is extremely limited. The provided research includes only a few relevant studies, with most focusing on efficacy rather than comprehensive safety evaluation. The safety profile presented here should be considered preliminary.
Known Side Effects
Based on the limited available evidence, specific side effects of magnesium threonate are not well-documented in the provided research. The studies referenced do not provide detailed adverse event profiles for this compound specifically.
Evidence gap: No comprehensive safety studies or systematic adverse event reporting for magnesium threonate were found in the provided evidence.
General Magnesium-Related Considerations
While not specific to magnesium threonate, magnesium supplementation in general may be associated with gastrointestinal effects, though the threonate form's specific tolerability profile requires further investigation.
Contraindications
Evidence limitation: The provided research does not establish specific contraindications for magnesium threonate.
Drug Interactions
No evidence provided: The available studies do not investigate potential drug interactions with magnesium threonate.
Populations That Should Exercise Caution
Evidence gap: The provided research does not identify specific populations who should avoid magnesium threonate, though one study (PMID: 41985648) examined its effects in a disease model (cyclophosphamide-induced cystitis), suggesting potential therapeutic applications rather than safety concerns.
Clinical Trial Safety Data
Several clinical trials are listed (NCT03531684, NCT03601169, NCT06889584), including Phase 2 studies in early Alzheimer's disease and older adults, but specific safety outcomes from these trials are not provided in the available evidence.
Medical Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Individuals considering magnesium threonate supplementation should consult with a healthcare provider, particularly given the limited safety data currently available for this specific compound.
Critical Evidence Gap: The safety profile of magnesium threonate requires substantial additional research, including systematic adverse event monitoring, drug interaction studies, and identification of contraindicated populations.